Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Trends in Genetics : TIG
|
January 22, 2013
Synthetic lethality and cancer: cohesin and PARP at the replication fork
Nigel J O'Neil, Derek M van Pel, Philip Hieter
Human Pathology
|
September 30, 2023
Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma
Derek M van Pel, Simon Cheung, Diana N Ionescu, et al.
Journal of Cell Communication and Signaling
|
June 18, 2018
Modelling glioma invasion using 3D bioprinting and scaffold-free 3D culture
Derek M van Pel, Kaori Harada, Dandan Song, et al.
G3 (Bethesda, Md.)
|
February 8, 2013
Saccharomyces cerevisiae genetics predicts candidate therapeutic genetic interactions at the mammalian replication fork
Derek M van Pel, Peter C Stirling, Sean W Minaker, et al.
Molecular Cancer Therapeutics
|
December 21, 2013
Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition
Melanie L Bailey, Nigel J O'Neil, Derek M van Pel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 13, 2022
Distinct Uroplakin II Staining Pattern in Apocrine Breast Carcinoma
Derek M van Pel, Jennifer Pors, Eddie Yuen, et al.
Plos Genetics
|
April 29, 2016
The MADD-3 LAMMER Kinase Interacts with a p38 MAP Kinase Pathway to Regulate the Display of the EVA-1 Guidance Receptor in Caenorhabditis elegans
Serena A D'Souza, Luckshi Rajendran, Rachel Bagg, et al.
Plos Genetics
|
February 6, 2013
An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development
Derek M van Pel, Irene J Barrett, Yoko Shimizu, et al.
Plos Genetics
|
March 14, 2012
Synthetic lethality of cohesins with PARPs and replication fork mediators
Jessica L McLellan, Nigel J O'Neil, Irene Barrett, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Trends in Genetics : TIG
|
January 22, 2013
Synthetic lethality and cancer: cohesin and PARP at the replication fork
Nigel J O'Neil, Derek M van Pel, Philip Hieter
Human Pathology
|
September 30, 2023
Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma
Derek M van Pel, Simon Cheung, Diana N Ionescu, et al.
Journal of Cell Communication and Signaling
|
June 18, 2018
Modelling glioma invasion using 3D bioprinting and scaffold-free 3D culture
Derek M van Pel, Kaori Harada, Dandan Song, et al.
G3 (Bethesda, Md.)
|
February 8, 2013
Saccharomyces cerevisiae genetics predicts candidate therapeutic genetic interactions at the mammalian replication fork
Derek M van Pel, Peter C Stirling, Sean W Minaker, et al.
Molecular Cancer Therapeutics
|
December 21, 2013
Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition
Melanie L Bailey, Nigel J O'Neil, Derek M van Pel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 13, 2022
Distinct Uroplakin II Staining Pattern in Apocrine Breast Carcinoma
Derek M van Pel, Jennifer Pors, Eddie Yuen, et al.
Plos Genetics
|
April 29, 2016
The MADD-3 LAMMER Kinase Interacts with a p38 MAP Kinase Pathway to Regulate the Display of the EVA-1 Guidance Receptor in Caenorhabditis elegans
Serena A D'Souza, Luckshi Rajendran, Rachel Bagg, et al.
Plos Genetics
|
February 6, 2013
An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development
Derek M van Pel, Irene J Barrett, Yoko Shimizu, et al.
Plos Genetics
|
March 14, 2012
Synthetic lethality of cohesins with PARPs and replication fork mediators
Jessica L McLellan, Nigel J O'Neil, Irene Barrett, et al.
Page
of 1